Back to Search

ALI MOHAMEDALI, PHARM.D.

PHARM.D.

Pharmacist

NPI: 1114359155Individual

Specialties, Licenses & Credentials

PharmacistPrimary

Pharmacist

Code: 183500000X

058257(NY)

Research & Publications (15)

Van-den Berghe's 5q- syndrome in 2008.
PMID 19016715·Br J Haematol·2009
6-review
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome.
PMID 19528370·J Clin Oncol·2009
8-other
Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients.
PMID 19016716·Br J Haematol·2009
8-other
AKT1 (E17K) mutation in pancreatic cancer.
PMID 18783292·Technol Cancer Res Treat·2008
8-other
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes.
PMID 17634407·Blood·2007
8-other
Immunotherapy of myeloid leukaemia.
PMID 17180671·Cancer Immunol Immunother·2007
6-review
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
PMID 18089795·Cancer Res·2007
7-preclinical
Leukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemia.
PMID 19662193·Biomark Insights·2007
8-other
Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia.
PMID 16673022·Leukemia·2006
5-case
The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow.
PMID 16617322·Leukemia·2006
4-observational
p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo.
PMID 16880527·Mol Cell Biol·2006
7-preclinical
The JAK2 V617F mutation is rare in RARS but common in RARS-T.
PMID 16932338·Leukemia·2006
4-observational
Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells.
PMID 15294172·Mol Ther·2004
7-preclinical
Cyclin D2 controls B cell progenitor numbers.
PMID 14612431·J Leukoc Biol·2003
4-observational
IL-2 gene and antisense TGF-beta1 strategies counteract HSV-2 transformed tumor progression.
PMID 12779352·Technol Cancer Res Treat·2003
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
7500 COMMONS BLVD
VICTOR, NY 14564

Location

Practice Location

7500 COMMONS BLVD, VICTOR, NY
(585) 425-2300

Quick Facts

NPI
1114359155
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
15

Are you this provider?

Claim Your Profile